JMP Securities analyst reaffirmed a positive outlook on Larimar Therapeutics (NASDAQ:LRMR), maintaining a Market Outperform ...

JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.

JMP Securities raised the firm’s price target on Exelixis (EXEL) to $41 from $34 and keeps an Outperform rating on the shares. Exelixis ...

Analyst Roy Buchanan of JMP Securities reiterated a Buy rating on Arbutus Biopharma (ABUS – Research Report), retaining the price target of ...

With all of the content available, it'll feel like you got your moneys worth during this free trial period. After signing up for the trial, you can test out Hulu completely free, with no ...

Amidst all of the increased competition and price increases happening across the streaming industry, a Hulu free trial is a brilliant way to try out one of the best streamers. And it actually exists!

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

To determine whether Crave is the best streaming choice for your household, it is recommended to take advantage of the free trial offer first. This will give you a good idea of the content ...

And if you’re a new member, you’ll receive a seven-day free trial. This is perfect in that it allows you to test drive the service, see if the interface is easy to use, and whether it’s the ...

JMP Securities expressed concerns that even in ... has shown interest in participating in Google's upcoming U.S. antitrust trial, focusing on online search. The company wishes to protect revenue ...

A jury will resume considering its verdict on Friday in the trial of law professor Diarmuid Phelan who denies the murder of a trespasser on his Co Dublin farm. Mr Phelan (56), a senior counsel and ...